News and press mentions

Latest news


01.11.23

STEM-OA Clinical Trial Application approved by Danish Medicines Agency

30.10.23

Stemform® approved by the Human Tissue Authority in the UK

17.10.23

StemMedical featured at LSI Emerging MedTech 2023

10.07.23

LSX World Congress 2023

06.07.23

Stem cells – A reality check on our journey to the promised land

20.06.23

StemMedical raising up to EUR 18m Series B for stem cell therapy platform

27.06.23
20.06.23

Stamcelleselskab har sikret sig halvdelen af ønsket kapital (Danish Read)

27.06.23
 

Message from the CEO


I have a passion for succeeding in bringing evidence based stem cell based therapies to patients. I believe we are the first and only company in the world to overcome the three barriers that prevent stem cell based therapies reaching patients. We are now on a mission to develop our stem cell platform with partners and reach patients across the world.